Abstract

Plan For several years sulfadiazine and pyrimethamine have been used in the treatment of human and experimental toxoplasmosis with varying reports as to their efficacy. Very little work has been done, however, with regard to the effects of these drugs in experimental ocular toxoplasmosis in animals. These studies were designed to determine whether sulfadiazine alone, or in combination with pyrimethamine,* would suppress or prevent a local or systemic infection in guinea pigs after inoculation of Toxoplasma into the vitreous humor. We have previously reported 1 on the technique for these infections, the type of inflammation produced, and the evidence of systemic spread from the eye. Materials Young female guinea pigs weighing approximately 400 gm. were used. They all had negative dye-test titers at a 1:16 dilution. The amounts of the drugs administered to the guinea pigs were based on average human dosages of 4 gm. of sulfadiazine daily and 75

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.